Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center (CPC), Denver, Colorado, USA
Not yet recruiting - verified July 2015

The PaWS (Pedometer and Walking Study)

Condition:   Intermittent Claudication
Intervention:   Other: Pedometer
Sponsors:   University Health Network, Toronto;   St. Michael
Recruiting - verified July 2015

York Study of Unloading Shoes for Vascular Intermittent Claudication

Conditions:   Intermittent Claudication;   Peripheral Arterial Disease
Interventions:   Device: Unloading shoes;   Device: Unadapted control shoe
Sponsors:   York Teaching Hospitals NHS Foundation Trust;   University of York;   York St John University;   University of Salford
Not yet recruiting - verified July 2015

Fycompa in Subjects With Small Fiber Neuropathy (SFN)

Condition:   Neuropathy, Small Fiber
Interventions:   Drug: Fycompa;   Drug: Placebo
Sponsors:   PNA Center for Neurological Research;   Eisai Inc.
Not yet recruiting - verified July 2015

Influence of Diabetes on Lower Limb Amputation

Conditions:   Diabetes;   PAD
Intervention:  
Sponsors:   University of Glasgow;   NHS GG&C
Recruiting - verified July 2015

Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
Sponsor:   Celgene Corporation
Recruiting - verified July 2015

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: Ticagrelor;   Drug: Comparator
Sponsors:   AstraZeneca;   CPC Clinical Research
Recruiting - verified July 2015

Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization

Conditions:   Surgical Wound Infection;   Peripheral Vascular Diseases
Interventions:   Device: Prevena (Negative Pressure Wound Therapy Device);   Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing
Sponsors:   Western University, Canada;   Kinetic Concepts, Inc.
Recruiting - verified July 2015

Treadmill Pilot Trial

Conditions:   Post-thrombotic Syndrome;   May-Thurner Syndrome
Intervention:   Procedure: PTA & stenting
Sponsor:   Maastricht University Medical Center
Completed - verified July 2015

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Condition:   Peripheral Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   AstraZeneca
Active, not recruiting - verified July 2015

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Conditions:   Intermittent Claudication;   Peripheral Artery Disease
Interventions:   Biological: PLX-PAD Low dose;   Biological: PLX-PAD high doses;   Biological: Double Placebo;   Biological: high dose +Placebo
Sponsor:   Pluristem Ltd.
Recruiting - verified May 2015

Get CardioSmart

You're Invited